Li, W., Gupta, S. K., Han, W., Kundson, R. A., Nelson, S., Knutson, D., . . . Gupta, M. (2019). Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. J Hematol Oncol.
Stile di citazione ChicagoLi, Weiping, et al. "Targeting MYC Activity in Double-hit Lymphoma With MYC and BCL2 And/or BCL6 Rearrangements With Epigenetic Bromodomain Inhibitors." J Hematol Oncol 2019.
Citazione MLALi, Weiping, et al. "Targeting MYC Activity in Double-hit Lymphoma With MYC and BCL2 And/or BCL6 Rearrangements With Epigenetic Bromodomain Inhibitors." J Hematol Oncol 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.